By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Apogenix 

Im Neuenheimer Feld 584

Heidelberg    69120  Germany
Phone: 49-0-6221-58608-0 Fax: 49-0-6221-58608-10


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Apogenix To Present At Three Upcoming International Conferences 4/26/2017 9:27:56 AM
Apogenix Announces Initiation Of Clinical Development For Abbv-621 To Treat Solid And Hematologic Tumors By Partner AbbVie (ABBV) 4/11/2017 2:54:23 PM
Apogenix Presents Data On Novel Hexavalent TNF Receptor Agonists (HERA) At The Upcoming Annual Meeting Of AACR 3/20/2017 8:51:04 AM
Apogenix Reports Significant Progress In Collaboration With CANBridge Life Sciences 11/4/2016 3:47:18 PM
Apogenix To Present At Two Upcoming International Conferences 5/4/2016 9:34:36 AM
Apogenix To Present At Two Upcoming International Conferences 5/4/2016 9:15:06 AM
Preclinical Efficacy Data Of Apogenix' APG101 In Myelodysplastic Syndromes (MDS) Published In Oncotarget 3/24/2016 7:16:19 AM
Apogenix Receives €3 Million Grant For The Development Of A Companion Diagnostic Test For Lead Immuno-Oncology Candidate APG101 2/16/2016 9:06:25 AM
Apogenix Strengthens U.S. Patent Position For Lead Immuno-Oncology Candidate APG101 1/14/2016 7:40:55 AM
Apogenix Receives First Milestone Payment From CANbridge Licensing Agreement And Signs Amendment To Include Taiwan 1/7/2016 7:39:21 AM
1234
//-->